President Cyril Ramaphosa welcomed this Wednesday the announcement of an agreement between South African group BIOVAC and pharmaceutical companies Pfizer and BioNTech. Based on this understanding, the BIOVAC group will start producing, in two thousand and twenty-two, a vaccine against covid-19, in South Africa, which will be the first on the African continent. Said vaccine will be produced in the city of Cabo. This partnership will allow the supply of up to one hundred million doses per year to African countries. Ramaphosa assures that the announced agreement will contribute to the health security and sustainability of Africa, a continent that has less access to vaccines (RM) Source:Radio Moçambique Online

Tradução automática do artigo:Aceder ao artigo original

Leave a Reply

Your email address will not be published.